処方箋なしマウスリンスのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Non-prescription Mouthrinse Market Insights, Forecast to 2028

• レポートコード：QY2207E03611 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3日） • 産業分類：消費財

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の処方箋なしマウスリンスの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に処方箋なしマウスリンスの世界市場のxxx％を占める「アルコール」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「ハイパーマーケット＆スーパーマーケット」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の処方箋なしマウスリンスの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの処方箋なしマウスリンス市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの処方箋なしマウスリンス市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 処方箋なしマウスリンスのグローバル主要メーカーには、Johnson & Johnson、Sunstar、P&G、Lion、Colgate-Palmolive、Unilever、Church & Dwight、PIERAS CO、GSK、Caldwell Consumer Health、Weleda、Dentyl Active、Kao Corporation、NYSCPS、WEIMEIZI (GUANGDONG) CO.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 処方箋なしマウスリンス市場は、種類と用途によって区分されます。世界の処方箋なしマウスリンス市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 アルコール、ノンアルコール 【用途別セグメント】 ハイパーマーケット＆スーパーマーケット、コンビニ、オンライン販売 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 処方箋なしマウスリンス製品概要 - 種類別市場（アルコール、ノンアルコール） - 用途別市場（ハイパーマーケット＆スーパーマーケット、コンビニ、オンライン販売） - 調査の目的 ・エグゼクティブサマリー - 世界の処方箋なしマウスリンス販売量予測2017-2028 - 世界の処方箋なしマウスリンス売上予測2017-2028 - 処方箋なしマウスリンスの地域別販売量 - 処方箋なしマウスリンスの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別処方箋なしマウスリンス販売量 - 主要メーカー別処方箋なしマウスリンス売上 - 主要メーカー別処方箋なしマウスリンス価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（アルコール、ノンアルコール） - 処方箋なしマウスリンスの種類別販売量 - 処方箋なしマウスリンスの種類別売上 - 処方箋なしマウスリンスの種類別価格 ・用途別市場規模（ハイパーマーケット＆スーパーマーケット、コンビニ、オンライン販売） - 処方箋なしマウスリンスの用途別販売量 - 処方箋なしマウスリンスの用途別売上 - 処方箋なしマウスリンスの用途別価格 ・北米市場 - 北米の処方箋なしマウスリンス市場規模（種類別、用途別） - 主要国別の処方箋なしマウスリンス市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの処方箋なしマウスリンス市場規模（種類別、用途別） - 主要国別の処方箋なしマウスリンス市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の処方箋なしマウスリンス市場規模（種類別、用途別） - 主要国別の処方箋なしマウスリンス市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の処方箋なしマウスリンス市場規模（種類別、用途別） - 主要国別の処方箋なしマウスリンス市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの処方箋なしマウスリンス市場規模（種類別、用途別） - 主要国別の処方箋なしマウスリンス市場規模（トルコ、サウジアラビア） ・企業情報 Johnson & Johnson、Sunstar、P&G、Lion、Colgate-Palmolive、Unilever、Church & Dwight、PIERAS CO、GSK、Caldwell Consumer Health、Weleda、Dentyl Active、Kao Corporation、NYSCPS、WEIMEIZI (GUANGDONG) CO. ・産業チェーン及び販売チャネル分析 - 処方箋なしマウスリンスの産業チェーン分析 - 処方箋なしマウスリンスの原材料 - 処方箋なしマウスリンスの生産プロセス - 処方箋なしマウスリンスの販売及びマーケティング - 処方箋なしマウスリンスの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 処方箋なしマウスリンスの産業動向 - 処方箋なしマウスリンスのマーケットドライバー - 処方箋なしマウスリンスの課題 - 処方箋なしマウスリンスの阻害要因 ・主な調査結果

Market Analysis and Insights: Global Non-prescription Mouthrinse Market
Due to the COVID-19 pandemic, the global Non-prescription Mouthrinse market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Alcoholic accounting for % of the Non-prescription Mouthrinse global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hypermarket and Supermarket segment is altered to an % CAGR throughout this forecast period.
China Non-prescription Mouthrinse market size is valued at US$ million in 2021, while the US and Europe Non-prescription Mouthrinse are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Non-prescription Mouthrinse landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Non-prescription Mouthrinse include Johnson & Johnson, Sunstar, P&G, Lion, Colgate-Palmolive, Unilever, Church & Dwight, PIERAS CO and GSK, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Non-prescription Mouthrinse Scope and Segment
Non-prescription Mouthrinse market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Non-prescription Mouthrinse market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Alcoholic
Non-alcoholic
Segment by Application
Hypermarket and Supermarket
Convenience Stores
Online Sale
By Company
Johnson & Johnson
Sunstar
P&G
Lion
Colgate-Palmolive
Unilever
Church & Dwight
PIERAS CO
GSK
Caldwell Consumer Health
Weleda
Dentyl Active
Kao Corporation
NYSCPS
WEIMEIZI (GUANGDONG) CO.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Non-prescription Mouthrinse Product Introduction
1.2 Market by Type
1.2.1 Global Non-prescription Mouthrinse Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Alcoholic
1.2.3 Non-alcoholic
1.3 Market by Application
1.3.1 Global Non-prescription Mouthrinse Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hypermarket and Supermarket
1.3.3 Convenience Stores
1.3.4 Online Sale
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Non-prescription Mouthrinse Sales Estimates and Forecasts 2017-2028
2.2 Global Non-prescription Mouthrinse Revenue Estimates and Forecasts 2017-2028
2.3 Global Non-prescription Mouthrinse Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Non-prescription Mouthrinse Sales by Region
2.4.1 Global Non-prescription Mouthrinse Sales by Region (2017-2022)
2.4.2 Global Sales Non-prescription Mouthrinse by Region (2023-2028)
2.5 Global Non-prescription Mouthrinse Revenue by Region
2.5.1 Global Non-prescription Mouthrinse Revenue by Region (2017-2022)
2.5.2 Global Non-prescription Mouthrinse Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Non-prescription Mouthrinse Sales by Manufacturers
3.1.1 Global Top Non-prescription Mouthrinse Manufacturers by Sales (2017-2022)
3.1.2 Global Non-prescription Mouthrinse Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-prescription Mouthrinse in 2021
3.2 Global Non-prescription Mouthrinse Revenue by Manufacturers
3.2.1 Global Non-prescription Mouthrinse Revenue by Manufacturers (2017-2022)
3.2.2 Global Non-prescription Mouthrinse Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Non-prescription Mouthrinse Revenue in 2021
3.3 Global Non-prescription Mouthrinse Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Non-prescription Mouthrinse Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Non-prescription Mouthrinse Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Non-prescription Mouthrinse Sales by Type
4.1.1 Global Non-prescription Mouthrinse Historical Sales by Type (2017-2022)
4.1.2 Global Non-prescription Mouthrinse Forecasted Sales by Type (2023-2028)
4.1.3 Global Non-prescription Mouthrinse Sales Market Share by Type (2017-2028)
4.2 Global Non-prescription Mouthrinse Revenue by Type
4.2.1 Global Non-prescription Mouthrinse Historical Revenue by Type (2017-2022)
4.2.2 Global Non-prescription Mouthrinse Forecasted Revenue by Type (2023-2028)
4.2.3 Global Non-prescription Mouthrinse Revenue Market Share by Type (2017-2028)
4.3 Global Non-prescription Mouthrinse Price by Type
4.3.1 Global Non-prescription Mouthrinse Price by Type (2017-2022)
4.3.2 Global Non-prescription Mouthrinse Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Non-prescription Mouthrinse Sales by Application
5.1.1 Global Non-prescription Mouthrinse Historical Sales by Application (2017-2022)
5.1.2 Global Non-prescription Mouthrinse Forecasted Sales by Application (2023-2028)
5.1.3 Global Non-prescription Mouthrinse Sales Market Share by Application (2017-2028)
5.2 Global Non-prescription Mouthrinse Revenue by Application
5.2.1 Global Non-prescription Mouthrinse Historical Revenue by Application (2017-2022)
5.2.2 Global Non-prescription Mouthrinse Forecasted Revenue by Application (2023-2028)
5.2.3 Global Non-prescription Mouthrinse Revenue Market Share by Application (2017-2028)
5.3 Global Non-prescription Mouthrinse Price by Application
5.3.1 Global Non-prescription Mouthrinse Price by Application (2017-2022)
5.3.2 Global Non-prescription Mouthrinse Price Forecast by Application (2023-2028)
6 North America
6.1 North America Non-prescription Mouthrinse Market Size by Type
6.1.1 North America Non-prescription Mouthrinse Sales by Type (2017-2028)
6.1.2 North America Non-prescription Mouthrinse Revenue by Type (2017-2028)
6.2 North America Non-prescription Mouthrinse Market Size by Application
6.2.1 North America Non-prescription Mouthrinse Sales by Application (2017-2028)
6.2.2 North America Non-prescription Mouthrinse Revenue by Application (2017-2028)
6.3 North America Non-prescription Mouthrinse Market Size by Country
6.3.1 North America Non-prescription Mouthrinse Sales by Country (2017-2028)
6.3.2 North America Non-prescription Mouthrinse Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Non-prescription Mouthrinse Market Size by Type
7.1.1 Europe Non-prescription Mouthrinse Sales by Type (2017-2028)
7.1.2 Europe Non-prescription Mouthrinse Revenue by Type (2017-2028)
7.2 Europe Non-prescription Mouthrinse Market Size by Application
7.2.1 Europe Non-prescription Mouthrinse Sales by Application (2017-2028)
7.2.2 Europe Non-prescription Mouthrinse Revenue by Application (2017-2028)
7.3 Europe Non-prescription Mouthrinse Market Size by Country
7.3.1 Europe Non-prescription Mouthrinse Sales by Country (2017-2028)
7.3.2 Europe Non-prescription Mouthrinse Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Non-prescription Mouthrinse Market Size by Type
8.1.1 Asia Pacific Non-prescription Mouthrinse Sales by Type (2017-2028)
8.1.2 Asia Pacific Non-prescription Mouthrinse Revenue by Type (2017-2028)
8.2 Asia Pacific Non-prescription Mouthrinse Market Size by Application
8.2.1 Asia Pacific Non-prescription Mouthrinse Sales by Application (2017-2028)
8.2.2 Asia Pacific Non-prescription Mouthrinse Revenue by Application (2017-2028)
8.3 Asia Pacific Non-prescription Mouthrinse Market Size by Region
8.3.1 Asia Pacific Non-prescription Mouthrinse Sales by Region (2017-2028)
8.3.2 Asia Pacific Non-prescription Mouthrinse Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Non-prescription Mouthrinse Market Size by Type
9.1.1 Latin America Non-prescription Mouthrinse Sales by Type (2017-2028)
9.1.2 Latin America Non-prescription Mouthrinse Revenue by Type (2017-2028)
9.2 Latin America Non-prescription Mouthrinse Market Size by Application
9.2.1 Latin America Non-prescription Mouthrinse Sales by Application (2017-2028)
9.2.2 Latin America Non-prescription Mouthrinse Revenue by Application (2017-2028)
9.3 Latin America Non-prescription Mouthrinse Market Size by Country
9.3.1 Latin America Non-prescription Mouthrinse Sales by Country (2017-2028)
9.3.2 Latin America Non-prescription Mouthrinse Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Non-prescription Mouthrinse Market Size by Type
10.1.1 Middle East and Africa Non-prescription Mouthrinse Sales by Type (2017-2028)
10.1.2 Middle East and Africa Non-prescription Mouthrinse Revenue by Type (2017-2028)
10.2 Middle East and Africa Non-prescription Mouthrinse Market Size by Application
10.2.1 Middle East and Africa Non-prescription Mouthrinse Sales by Application (2017-2028)
10.2.2 Middle East and Africa Non-prescription Mouthrinse Revenue by Application (2017-2028)
10.3 Middle East and Africa Non-prescription Mouthrinse Market Size by Country
10.3.1 Middle East and Africa Non-prescription Mouthrinse Sales by Country (2017-2028)
10.3.2 Middle East and Africa Non-prescription Mouthrinse Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Johnson & Johnson Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Sunstar
11.2.1 Sunstar Corporation Information
11.2.2 Sunstar Overview
11.2.3 Sunstar Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sunstar Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sunstar Recent Developments
11.3 P&G
11.3.1 P&G Corporation Information
11.3.2 P&G Overview
11.3.3 P&G Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 P&G Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 P&G Recent Developments
11.4 Lion
11.4.1 Lion Corporation Information
11.4.2 Lion Overview
11.4.3 Lion Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Lion Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lion Recent Developments
11.5 Colgate-Palmolive
11.5.1 Colgate-Palmolive Corporation Information
11.5.2 Colgate-Palmolive Overview
11.5.3 Colgate-Palmolive Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Colgate-Palmolive Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Colgate-Palmolive Recent Developments
11.6 Unilever
11.6.1 Unilever Corporation Information
11.6.2 Unilever Overview
11.6.3 Unilever Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Unilever Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Unilever Recent Developments
11.7 Church & Dwight
11.7.1 Church & Dwight Corporation Information
11.7.2 Church & Dwight Overview
11.7.3 Church & Dwight Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Church & Dwight Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Church & Dwight Recent Developments
11.8 PIERAS CO
11.8.1 PIERAS CO Corporation Information
11.8.2 PIERAS CO Overview
11.8.3 PIERAS CO Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 PIERAS CO Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 PIERAS CO Recent Developments
11.9 GSK
11.9.1 GSK Corporation Information
11.9.2 GSK Overview
11.9.3 GSK Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 GSK Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 GSK Recent Developments
11.10 Caldwell Consumer Health
11.10.1 Caldwell Consumer Health Corporation Information
11.10.2 Caldwell Consumer Health Overview
11.10.3 Caldwell Consumer Health Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Caldwell Consumer Health Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Caldwell Consumer Health Recent Developments
11.11 Weleda
11.11.1 Weleda Corporation Information
11.11.2 Weleda Overview
11.11.3 Weleda Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Weleda Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Weleda Recent Developments
11.12 Dentyl Active
11.12.1 Dentyl Active Corporation Information
11.12.2 Dentyl Active Overview
11.12.3 Dentyl Active Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Dentyl Active Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Dentyl Active Recent Developments
11.13 Kao Corporation
11.13.1 Kao Corporation Corporation Information
11.13.2 Kao Corporation Overview
11.13.3 Kao Corporation Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Kao Corporation Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Kao Corporation Recent Developments
11.14 NYSCPS
11.14.1 NYSCPS Corporation Information
11.14.2 NYSCPS Overview
11.14.3 NYSCPS Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 NYSCPS Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 NYSCPS Recent Developments
11.15 WEIMEIZI (GUANGDONG) CO.
11.15.1 WEIMEIZI (GUANGDONG) CO. Corporation Information
11.15.2 WEIMEIZI (GUANGDONG) CO. Overview
11.15.3 WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 WEIMEIZI (GUANGDONG) CO. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Non-prescription Mouthrinse Industry Chain Analysis
12.2 Non-prescription Mouthrinse Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Non-prescription Mouthrinse Production Mode & Process
12.4 Non-prescription Mouthrinse Sales and Marketing
12.4.1 Non-prescription Mouthrinse Sales Channels
12.4.2 Non-prescription Mouthrinse Distributors
12.5 Non-prescription Mouthrinse Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Non-prescription Mouthrinse Industry Trends
13.2 Non-prescription Mouthrinse Market Drivers
13.3 Non-prescription Mouthrinse Market Challenges
13.4 Non-prescription Mouthrinse Market Restraints
14 Key Findings in The Global Non-prescription Mouthrinse Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Non-prescription Mouthrinse Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Alcoholic
Table 3. Major Manufacturers of Non-alcoholic
Table 4. Global Non-prescription Mouthrinse Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Non-prescription Mouthrinse Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Non-prescription Mouthrinse Sales by Region (2017-2022) & (K Units)
Table 7. Global Non-prescription Mouthrinse Sales Market Share by Region (2017-2022)
Table 8. Global Non-prescription Mouthrinse Sales by Region (2023-2028) & (K Units)
Table 9. Global Non-prescription Mouthrinse Sales Market Share by Region (2023-2028)
Table 10. Global Non-prescription Mouthrinse Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Non-prescription Mouthrinse Revenue Market Share by Region (2017-2022)
Table 12. Global Non-prescription Mouthrinse Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Non-prescription Mouthrinse Revenue Market Share by Region (2023-2028)
Table 14. Global Non-prescription Mouthrinse Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Non-prescription Mouthrinse Sales Share by Manufacturers (2017-2022)
Table 16. Global Non-prescription Mouthrinse Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Non-prescription Mouthrinse Revenue Share by Manufacturers (2017-2022)
Table 18. Non-prescription Mouthrinse Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Non-prescription Mouthrinse Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Non-prescription Mouthrinse by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-prescription Mouthrinse as of 2021)
Table 21. Non-prescription Mouthrinse Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Non-prescription Mouthrinse Product Offered
Table 23. Date of Manufacturers Enter into Non-prescription Mouthrinse Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Non-prescription Mouthrinse Sales by Type (2017-2022) & (K Units)
Table 26. Global Non-prescription Mouthrinse Sales by Type (2023-2028) & (K Units)
Table 27. Global Non-prescription Mouthrinse Sales Share by Type (2017-2022)
Table 28. Global Non-prescription Mouthrinse Sales Share by Type (2023-2028)
Table 29. Global Non-prescription Mouthrinse Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Non-prescription Mouthrinse Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Non-prescription Mouthrinse Revenue Share by Type (2017-2022)
Table 32. Global Non-prescription Mouthrinse Revenue Share by Type (2023-2028)
Table 33. Non-prescription Mouthrinse Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Non-prescription Mouthrinse Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Non-prescription Mouthrinse Sales by Application (2017-2022) & (K Units)
Table 36. Global Non-prescription Mouthrinse Sales by Application (2023-2028) & (K Units)
Table 37. Global Non-prescription Mouthrinse Sales Share by Application (2017-2022)
Table 38. Global Non-prescription Mouthrinse Sales Share by Application (2023-2028)
Table 39. Global Non-prescription Mouthrinse Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Non-prescription Mouthrinse Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Non-prescription Mouthrinse Revenue Share by Application (2017-2022)
Table 42. Global Non-prescription Mouthrinse Revenue Share by Application (2023-2028)
Table 43. Non-prescription Mouthrinse Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Non-prescription Mouthrinse Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Non-prescription Mouthrinse Sales by Type (2017-2022) & (K Units)
Table 46. North America Non-prescription Mouthrinse Sales by Type (2023-2028) & (K Units)
Table 47. North America Non-prescription Mouthrinse Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Non-prescription Mouthrinse Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Non-prescription Mouthrinse Sales by Application (2017-2022) & (K Units)
Table 50. North America Non-prescription Mouthrinse Sales by Application (2023-2028) & (K Units)
Table 51. North America Non-prescription Mouthrinse Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Non-prescription Mouthrinse Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Non-prescription Mouthrinse Sales by Country (2017-2022) & (K Units)
Table 54. North America Non-prescription Mouthrinse Sales by Country (2023-2028) & (K Units)
Table 55. North America Non-prescription Mouthrinse Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Non-prescription Mouthrinse Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Non-prescription Mouthrinse Sales by Type (2017-2022) & (K Units)
Table 58. Europe Non-prescription Mouthrinse Sales by Type (2023-2028) & (K Units)
Table 59. Europe Non-prescription Mouthrinse Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Non-prescription Mouthrinse Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Non-prescription Mouthrinse Sales by Application (2017-2022) & (K Units)
Table 62. Europe Non-prescription Mouthrinse Sales by Application (2023-2028) & (K Units)
Table 63. Europe Non-prescription Mouthrinse Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Non-prescription Mouthrinse Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Non-prescription Mouthrinse Sales by Country (2017-2022) & (K Units)
Table 66. Europe Non-prescription Mouthrinse Sales by Country (2023-2028) & (K Units)
Table 67. Europe Non-prescription Mouthrinse Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Non-prescription Mouthrinse Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Non-prescription Mouthrinse Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Non-prescription Mouthrinse Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Non-prescription Mouthrinse Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Non-prescription Mouthrinse Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Non-prescription Mouthrinse Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Non-prescription Mouthrinse Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Non-prescription Mouthrinse Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Non-prescription Mouthrinse Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Non-prescription Mouthrinse Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Non-prescription Mouthrinse Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Non-prescription Mouthrinse Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Non-prescription Mouthrinse Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Non-prescription Mouthrinse Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Non-prescription Mouthrinse Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Non-prescription Mouthrinse Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Non-prescription Mouthrinse Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Non-prescription Mouthrinse Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Non-prescription Mouthrinse Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Non-prescription Mouthrinse Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Non-prescription Mouthrinse Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Non-prescription Mouthrinse Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Non-prescription Mouthrinse Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Non-prescription Mouthrinse Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Non-prescription Mouthrinse Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Non-prescription Mouthrinse Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Non-prescription Mouthrinse Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Non-prescription Mouthrinse Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Non-prescription Mouthrinse Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Non-prescription Mouthrinse Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Non-prescription Mouthrinse Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Non-prescription Mouthrinse Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Non-prescription Mouthrinse Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Non-prescription Mouthrinse Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Non-prescription Mouthrinse Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Non-prescription Mouthrinse Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Non-prescription Mouthrinse Revenue by Country (2023-2028) & (US$ Million)
Table 105. Johnson & Johnson Corporation Information
Table 106. Johnson & Johnson Description and Major Businesses
Table 107. Johnson & Johnson Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Johnson & Johnson Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Johnson & Johnson Recent Developments
Table 110. Sunstar Corporation Information
Table 111. Sunstar Description and Major Businesses
Table 112. Sunstar Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Sunstar Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Sunstar Recent Developments
Table 115. P&G Corporation Information
Table 116. P&G Description and Major Businesses
Table 117. P&G Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. P&G Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. P&G Recent Developments
Table 120. Lion Corporation Information
Table 121. Lion Description and Major Businesses
Table 122. Lion Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Lion Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Lion Recent Developments
Table 125. Colgate-Palmolive Corporation Information
Table 126. Colgate-Palmolive Description and Major Businesses
Table 127. Colgate-Palmolive Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Colgate-Palmolive Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Colgate-Palmolive Recent Developments
Table 130. Unilever Corporation Information
Table 131. Unilever Description and Major Businesses
Table 132. Unilever Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Unilever Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Unilever Recent Developments
Table 135. Church & Dwight Corporation Information
Table 136. Church & Dwight Description and Major Businesses
Table 137. Church & Dwight Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Church & Dwight Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Church & Dwight Recent Developments
Table 140. PIERAS CO Corporation Information
Table 141. PIERAS CO Description and Major Businesses
Table 142. PIERAS CO Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. PIERAS CO Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. PIERAS CO Recent Developments
Table 145. GSK Corporation Information
Table 146. GSK Description and Major Businesses
Table 147. GSK Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. GSK Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. GSK Recent Developments
Table 150. Caldwell Consumer Health Corporation Information
Table 151. Caldwell Consumer Health Description and Major Businesses
Table 152. Caldwell Consumer Health Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Caldwell Consumer Health Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Caldwell Consumer Health Recent Developments
Table 155. Weleda Corporation Information
Table 156. Weleda Description and Major Businesses
Table 157. Weleda Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. Weleda Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Weleda Recent Developments
Table 160. Dentyl Active Corporation Information
Table 161. Dentyl Active Description and Major Businesses
Table 162. Dentyl Active Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. Dentyl Active Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Dentyl Active Recent Developments
Table 165. Kao Corporation Corporation Information
Table 166. Kao Corporation Description and Major Businesses
Table 167. Kao Corporation Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 168. Kao Corporation Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Kao Corporation Recent Developments
Table 170. NYSCPS Corporation Information
Table 171. NYSCPS Description and Major Businesses
Table 172. NYSCPS Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 173. NYSCPS Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. NYSCPS Recent Developments
Table 175. WEIMEIZI (GUANGDONG) CO. Corporation Information
Table 176. WEIMEIZI (GUANGDONG) CO. Description and Major Businesses
Table 177. WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 178. WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. WEIMEIZI (GUANGDONG) CO. Recent Developments
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Non-prescription Mouthrinse Distributors List
Table 183. Non-prescription Mouthrinse Customers List
Table 184. Non-prescription Mouthrinse Market Trends
Table 185. Non-prescription Mouthrinse Market Drivers
Table 186. Non-prescription Mouthrinse Market Challenges
Table 187. Non-prescription Mouthrinse Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-prescription Mouthrinse Product Picture
Figure 3. Global Non-prescription Mouthrinse Market Share by Type in 2021 & 2028
Figure 3. Alcoholic Product Picture
Figure 4. Non-alcoholic Product Picture
Figure 5. Global Non-prescription Mouthrinse Market Share by Application in 2021 & 2028
Figure 6. Hypermarket and Supermarket
Figure 7. Convenience Stores
Figure 8. Online Sale
Figure 9. Non-prescription Mouthrinse Report Years Considered
Figure 10. Global Non-prescription Mouthrinse Sales 2017-2028 (K Units)
Figure 11. Global Non-prescription Mouthrinse Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Non-prescription Mouthrinse Revenue 2017-2028 (US$ Million)
Figure 13. Global Non-prescription Mouthrinse Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Non-prescription Mouthrinse Sales Market Share by Region (2017-2022)
Figure 15. Global Non-prescription Mouthrinse Sales Market Share by Region (2023-2028)
Figure 16. North America Non-prescription Mouthrinse Sales YoY (2017-2028) & (K Units)
Figure 17. North America Non-prescription Mouthrinse Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Non-prescription Mouthrinse Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Non-prescription Mouthrinse Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Non-prescription Mouthrinse Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Non-prescription Mouthrinse Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Non-prescription Mouthrinse Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Non-prescription Mouthrinse Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Non-prescription Mouthrinse Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Non-prescription Mouthrinse Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Non-prescription Mouthrinse Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Non-prescription Mouthrinse in the World: Market Share by Non-prescription Mouthrinse Revenue in 2021
Figure 28. Global Non-prescription Mouthrinse Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Non-prescription Mouthrinse Sales Market Share by Type (2017-2028)
Figure 30. Global Non-prescription Mouthrinse Revenue Market Share by Type (2017-2028)
Figure 31. Global Non-prescription Mouthrinse Sales Market Share by Application (2017-2028)
Figure 32. Global Non-prescription Mouthrinse Revenue Market Share by Application (2017-2028)
Figure 33. North America Non-prescription Mouthrinse Sales Market Share by Type (2017-2028)
Figure 34. North America Non-prescription Mouthrinse Revenue Market Share by Type (2017-2028)
Figure 35. North America Non-prescription Mouthrinse Sales Market Share by Application (2017-2028)
Figure 36. North America Non-prescription Mouthrinse Revenue Market Share by Application (2017-2028)
Figure 37. North America Non-prescription Mouthrinse Sales Share by Country (2017-2028)
Figure 38. North America Non-prescription Mouthrinse Revenue Share by Country (2017-2028)
Figure 39. United States Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Non-prescription Mouthrinse Sales Market Share by Type (2017-2028)
Figure 42. Europe Non-prescription Mouthrinse Revenue Market Share by Type (2017-2028)
Figure 43. Europe Non-prescription Mouthrinse Sales Market Share by Application (2017-2028)
Figure 44. Europe Non-prescription Mouthrinse Revenue Market Share by Application (2017-2028)
Figure 45. Europe Non-prescription Mouthrinse Sales Share by Country (2017-2028)
Figure 46. Europe Non-prescription Mouthrinse Revenue Share by Country (2017-2028)
Figure 47. Germany Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 48. France Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Non-prescription Mouthrinse Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Non-prescription Mouthrinse Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Non-prescription Mouthrinse Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Non-prescription Mouthrinse Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Non-prescription Mouthrinse Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Non-prescription Mouthrinse Revenue Share by Region (2017-2028)
Figure 58. China Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 61. India Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Non-prescription Mouthrinse Sales Market Share by Type (2017-2028)
Figure 68. Latin America Non-prescription Mouthrinse Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Non-prescription Mouthrinse Sales Market Share by Application (2017-2028)
Figure 70. Latin America Non-prescription Mouthrinse Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Non-prescription Mouthrinse Sales Share by Country (2017-2028)
Figure 72. Latin America Non-prescription Mouthrinse Revenue Share by Country (2017-2028)
Figure 73. Mexico Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 76. Colombia Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Non-prescription Mouthrinse Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Non-prescription Mouthrinse Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Non-prescription Mouthrinse Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Non-prescription Mouthrinse Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Non-prescription Mouthrinse Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Non-prescription Mouthrinse Revenue Share by Country (2017-2028)
Figure 83. Turkey Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Non-prescription Mouthrinse Revenue (2017-2028) & (US$ Million)
Figure 86. Non-prescription Mouthrinse Value Chain
Figure 87. Non-prescription Mouthrinse Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---